1. AB0281 SAFETY AND RETENTION RATE AFTER SWITCHING FROM ETANERCEPT ORIGINATOR (ETN) TO ETANERCEPT BIOSIMILAR (SB4) IN INFLAMMATORY JOINT DISEASES: DATA FROM REAL LIFE. (2nd June 2020) Authors: Bruni, C.; Gentileschi, S.; Capassoni, M.; Pacini, G.; Bardelli, M.; Baldi, C.; Tofani, L.; Cometi, L.; Nacci, F.; Bartoli, F.; Fiori, G.; Cantarini, L.; Guiducci, S.; Frediani, B.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0361 EFFICACY AND SAFETY OF BARICITINIB (BARI) IN RHEUMATOID ARTHRITIS(RA): CLINICAL AND ULTRASOUND EVALUATION IN REAL LIFE. (2nd June 2020) Authors: Tesei, G.; Bruni, C.; Cometi, L.; Nacci, F.; Capassoni, M.; Terenzi, R.; Tofani, L.; Bartoli, F.; Fiori, G.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1035 Ultra-low dose anti-interleukin1 in chronic gout: a safe and successful combination therapy with low dose colchicine and urate lowering agents. (12th June 2018) Authors: Capassoni, M.; Galluccio, F.; Matucci Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗